Europe

Who is gaining share as US investors pile into Europe?

American participation took up almost 20% of the continent’s total deal count last year.
Purebred Arabian horses in Turkiye's Malatya

Anadolu via Getty Images

US investors’ interest in Europe continues to grow as they seek to diversify away from their crowded home market and seek deals trading at a discount.

In 2025, PE deal activity with US investor participation accounted for almost 20% of the total deal count in Europe.

Among the major markets, US investors remain most frequently involved in UK deals, with their participation rate edging up from 29.5% to 32.6%.

France had a modest increase in US participation, remaining steady at around 12% of PE deal count, while Portugal saw the biggest jump, from 11.2% in 2024 to 18.3% in 2025.

This article appeared as part of The Europe Pitch newsletter. Subscribe here

However, not all countries are benefiting from US investors’ increased appetite for European PE deals.

Germany, despite being Europe’s largest economy, had a slight decrease in deals with US participation from 19.2% to 18.8%.

Spain and Switzerland also saw drops of 3.5 and 5.2 percentage points over the past year, respectively.

In addition to lower valuations, US capital is drawn to Europe as faster monetary easing has created a more favorable trade environment for investors. The fragmentation in European markets also generates more mid-market opportunities for treasure-seekers, a segment of the market that has been struggling of late in the US.

According to PitchBook’s 2026 EMEA Private Capital Outlook, US investor participation is expected to reach 25% of European PE deal count this year.

Latest Research

Aerospace & Defense Report: Defense on the Rise

The Q3 2026 Aerospace & Defense Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

Some major European PE deals involving US investors last year include Qatar Investment Authority and The Carlyle Group‘s agreed carve-out of the industrial coatings business of
German chemicals company BASF for €7.7 billion (about $9.2 billion) in October.

Clayton, Dubilier & Rice also carved out Opella, Sanofi’s consumer healthcare business, for €8 billion in March.

Sign up for The Europe Pitch

Get our daily digest of private capital markets in the EMEA region.

Recent News

Weil Gotshal quietly incubated an AI-native Big Law challenger before its collapse

The new company, Kepler, is looking to raise hundreds of millions of dollars and will target high-margin M&A work with an eye to launching in Q1 2027.

Why Wall Street wants to trade AI compute like oil

A new boom in tech industrialization changes the face of Silicon Valley’s capital stack.

Learn about our editorial standards.